Boehringer Ingelheim and Alpha Pharma Collaborate to localize the production of one of its Type 2 Diabetes Medicines in Saudi Arabia
Boehringer Ingelheim is driving localization capacities with robust partnerships in alignment with Vision 2030
Search
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Innovation Prize Winners
Find out more about the winners of our Innovation Prize in Boston, New York and San Diego in the USA; Tokyo Japan and Vienna, Austria
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Open Innovation at Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Human Health Innovation
Human Health Innovation
Science & Innovation
Science & Innovation
Animal Health Innovation
Animal Health Innovation
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Driving Innovation through Diversity & Inclusion
Driving innovation through diversity and inclusion. Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work.
About Our Innovation Prize
About Our Innovation Prize
1990-2022: Value through Innovation
The Boehringer Ingelheim history from 1990 to 2022, with milestones
Research and Development Pipeline
Find out more about our human pharma research and development pipeline
Digital innovation: “Our digital pipeline is only growing”
Digital innovation: “Our digital pipeline is only growing”
Interview with Eric Haaksma, Head of Animal Health Global Innovation
Interview with Eric Haaksma, Head of Animal Health Global Innovation
Industry 40 Innovation in France
Our sites in the Lyon area and Toulouse are investing in the industry of the future.
How BI Supports Grass Roots Innovation
Hear from life-science entrepreneurs about how we are supporting early-stage science through our innovative Grass Roots program.
Advancing regenerative medicine
Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Innovation in medicinal chemistry
Darryl McConnell, Senior Vice President and Research Site Head, Austria and Jürgen Mack, Vice-President, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Grass Roots
Grass Roots
Cardiometabolic Research
Read about our patient-centric approach to cardiometabolic disease research.
Patient Safety
Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView”
Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey